Month: April 2016

Dr Mark Kelson, Centre for Trials Research..

Methods: An Emerging Centre for Trials Research Theme

Posted on 26 April 2016 by Mark Kelson

It has been said that humans make an average of 35,000 decisions every day*. This seems like an underestimate when working in the Centre for Trials Research. Being part of a centre with 3 registered clinical trials units, we have many regulations and processes to follow; but anyone who has ever tried to answer a scientific question through
Read more

SCOPE2 Workshop delegates.

SCOPE2: Can Increasing The Dose Of Radiotherapy Improve Outcomes In Patients With Oesophageal Cancer?

Posted on 26 April 2016 by Ruby Ray

SCOPE2 is a randomised Phase II/III trial to study radiotherapy dose escalation in patients with oesophageal cancer treated with definitive chemo-radiation with an embedded Phase II trial for patients with a poor early response using positron emission tomography (PET). SCOPE2 is a Cancer Research UK funded trial run by the Wales Cancer Trials Unit based in the
Read more

MID-Frail And What A 102 Year Old Study Participant Is Teaching Us About What’s Possible

Posted on 18 April 2016 by Mark Kelson

The MID-Frail study investigates a complex intervention comprising dietary and education advice, physical activity and optimized care for this highly under-researched population.  The Centre for Trials Research is responsible for the statistical integrity of the study and will be in charge of conducting the analysis. As a FP7 European study, this is an important collaboration. The
Read more

PIN: A Trial Looking At Olaparib For Non Small Cell Lung Cancer

Posted on 13 April 2016 by Joanna Canham

In 2013, there were 45,525 new cases of lung cancer in the UK and it kills around 35,000 annually (Source: CRUK). Non-small cell lung cancer (NSCLC) accounts for around 87% of all lung cancer. NSCLC is one of the leading causes of death worldwide and presents a huge health economic burden. The majority of patients
Read more